Sign In
Buy GBT
$68.49
+0 (+0%)
At Close: Jan 27, 2023
Syros Reports Second Quarter 2020 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
12:00am, Thursday, 06'th Aug 2020
Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today reported financial results f
Global Blood Therapeutics (GBT) Reports Q2 Loss, Tops Revenue Estimates
09:35pm, Wednesday, 05'th Aug 2020
Global Blood (GBT) delivered earnings and revenue surprises of 27.12% and 67.11%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
GBT Reports Recent Business Progress and Second Quarter 2020 Financial Results
08:01pm, Wednesday, 05'th Aug 2020
Achieved Oxbryta® (voxelotor) net revenues of $31.5 million, with approximately 1,000 new patient prescriptions Announced plans to seek approval of Oxbryta for younger pediatric patients in t
The Daily Biotech Pulse: Novavax Vaccine Data, Aerpio Gets $5.1M Funding For COVID Trial, Rigel Gains Big On Earnings
12:00am, Wednesday, 05'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 4)
ABIOMED, Inc. (NASDAQ: ABMD) (FDA approved the emergency use of Abiomed's Impella heart pump in combination...
Is Global Blood Therapeutics (NASDAQ:GBT) Using Debt In A Risky Way?
04:54pm, Monday, 03'rd Aug 2020
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
GBT Announces Participation in Upcoming Investor Conferences
12:00pm, Thursday, 30'th Jul 2020
SOUTH SAN FRANCISCO, Calif. , July 30, 2020 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that members of the senior management team will participate in virtu
GBT to Announce Second Quarter 2020 Financial Results on Wednesday, August 5, 2020
12:00pm, Wednesday, 29'th Jul 2020
SOUTH SAN FRANCISCO, Calif., July 29, 2020 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will report second quarter 2020 financial results on Wednesda
CRISPR THERAPEUTICS AG Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
08:43pm, Monday, 27'th Jul 2020CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2020 Financial Results | MarketScreener
08:31pm, Monday, 27'th Jul 20203 Top Biotech Stocks to Buy Now
01:10pm, Saturday, 25'th Jul 2020
While large-cap biotech companies have been doing quite well, investors can frequently find market-beating performance in emerging biotechs developing cutting-edge treatments. First up is Ovid Therap
Global Blood Therapeutics (NASDAQ:GBT) Lifted to “Sell” at BidaskClub
05:32am, Saturday, 18'th Jul 2020
BidaskClub upgraded shares of Global Blood Therapeutics (NASDAQ:GBT) from a strong sell rating to a sell rating in a research report report published on Tuesday morning, BidAskClub reports. Several ot
Did Hedge Funds Make The Right Call On Global Blood Therapeutics Inc (GBT) ?
04:45pm, Friday, 17'th Jul 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
Is Intellia Therapeutics Stock a Buy? | The Motley Fool
11:07am, Tuesday, 14'th Jul 2020
Could this promising gene-editing company make you rich?
Global Blood Therapeutics (NASDAQ:GBT) Receives New Coverage from Analysts at BofA Securities
08:52am, Monday, 13'th Jul 2020
Research analysts at BofA Securities assumed coverage on shares of Global Blood Therapeutics (NASDAQ:GBT) in a research report issued on Monday, Briefing.com Automated Import reports. The firm set a �
